Literature DB >> 21115864

Relevance of the International Prognostic Index in the rituximab era.

Kevin Tay, David Tai, Miriam Tao, Richard Quek, Tam-Cam Ha, Soon-Thye Lim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21115864     DOI： 10.1200/JCO.2010.31.7677

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Clinical significance and functional validation of inorganic pyrophosphatase in diffuse large B cell lymphoma in humans.

Authors:  Limei Li; Dehong Luo; Arong Jin
Journal:  Cytotechnology       Date:  2017-12-12       Impact factor: 2.058

2.  Localized primary gastrointestinal diffuse large B cell lymphoma received a surgical approach: an analysis of prognostic factors and comparison of staging systems in 101 patients from a single institution.

Authors:  Shengting Zhang; Li Wang; Dong Yu; Yang Shen; Shu Cheng; Li Zhang; Ying Qian; Zhixiang Shen; Qinyu Li; Weili Zhao
Journal:  World J Surg Oncol       Date:  2015-08-15       Impact factor: 2.754

3.  Reassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study.

Authors:  Hong-Hui Huang; Fei Xiao; Fang-Yuan Chen; Ting Wang; Jun-Min Li; Jian-Min Wang; Jun-Ning Cao; Chun Wang; Shan-Hua Zou
Journal:  Exp Ther Med       Date:  2012-06-12       Impact factor: 2.447

4.  MYC translocation and/or BCL 2 protein expression are associated with poor prognosis in diffuse large B-cell lymphoma.

Authors:  Keisuke Kawamoto; Hiroaki Miyoshi; Noriaki Yoshida; Naoya Nakamura; Koichi Ohshima; Hirohito Sone; Jun Takizawa
Journal:  Cancer Sci       Date:  2016-05-06       Impact factor: 6.716
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.